Drug Affordability Reviews
A process where states, often through Prescription Drug Affordability Boards (PDABs), evaluate the costs of prescription drugs to improve affordability for consumers and manage healthcare spending.
AiArthritis Position Statement On Drug Affordability Reviews
Prescription Drug Affordability Boards (PDABs) do no result in drug cost savings to states or patients and upper payment limits or “price controls” set by PDABs can limit patient access to critically-needed medications, especially when patient input and medical needs are not considered.
Patient Written Glossary of Terms
Frequently, everyday terms when navigating a diagnosis of an AiArthritis Disease—such as "payer"—can lead to confusion. Therefore, we have developed a glossary to assist!
Discover Patient Journeys With Drug Affordability Reviews In Our Video Library!
The Patient-Instructed Video Library
The Patient-Instructed Video Library was created to help our community gain a deeper understanding of critical issues that affect access to health care. The goals of this initiative are to educate, inspire fellow patients to share their experiences, and empower our community to take action in addressing access-related challenges.
What are Government Drug Affordability Reviews? (Tiffany's Perspective)
Tiffany, CEO and a person with non-radiographic axial spondyloarthritis, discusses government reviews on prescription drug affordability. The Inflation Reduction Act and state-level PDABs are negotiating drug prices to lower costs. Learn how these efforts impact the healthcare system and patient expenses.
Government Drug Affordability Reviews - Why Should Patients Care? (Tiffany's Perspective)
Tiffany emphasizes the importance of patient involvement in government drug affordability reviews. Your feedback influences which drugs are reviewed and addresses medication costs. As processes evolve, your voice can significantly impact ensuring that savings benefit patients like you.
Government Drug Affordability Reviews - Why Should Patients Care? (Tiffany's Perspective #2)
Tiffany highlights why it's essential for patients to engage with government drug affordability reviews. While the goal is to lower drug costs, there are potential pitfalls. For example, even if drug prices go down, savings may not reach your pocket, or you could be forced to switch medications.
Government Drug Affordability Reviews Patient Story: Tiffany's Perspective
Tiffany shares her personal experience with Colorado’s Prescription Drug Affordability Board, where she testified on behalf of patients about drug affordability. Despite providing valuable patient data, her testimony was largely overlooked, with board members focusing on 'what if' scenarios instead of real patient experiences. Her story highlights how vital it is for patients to be heard in these reviews, as insurers may not always prioritize our needs.
Government Drug Affordability Reviews Patient Story: Ray's Perspective
Ray, a Psoriatic Arthritis patient advocate, highlights his experience with Colorado's Drug Affordability Review Board, noting their disconnect from real patient costs. Despite a $0 copay card, he faced over $2,800 in out-of-pocket expenses. He criticizes the lack of patient input and ineffective surveys that miss issues like insurance delays. Ray urges patients to complete AiArthritis' survey to ensure policymakers hear their stories and enhance drug affordability.
Learn More By Exploring Our Video Library
Did you know that access to healthcare and treatments is frequently tied to policies like government healthcare systems and insurance companies? Recognizing these influences and sharing YOUR experiences with legislators to illustrate the need for policy change is crucial!
Share Your Drug Affordability Review Experience
Would you share your experience with us? We’d like to hear how you navigated challenges in obtaining healthcare or treatments. What obstacles did you face, and how have they shaped your journey? Your insights could be invaluable to others in similar situations.
Class Is In Session! Drug Affordability Reviews
About The Classroom: Lead instructors, including our CEO Tiffany, who has non-radiographic axial spondyloarthritis (nr-axSpA) and is a former award-winning college instructor, will collaborate with Class Discussion Leaders living with our diseases to host engaging webinars and AiArthritis Voices 360 Talk Show segments.
Step Therapy Class: Most have experienced this health insurance protocol that requires us to fail a cheaper drug before being allowed to access the one prescribed by our doctor. Learn more about this issue & what you can do if it happens to you. In collaboration with The National Psoriasis Foundation
How To Get More Involved!
Ready to deepen your involvement? Share experiences to support our fight for change with AiArthritis—join us for co-writing letters, virtual Field Trips, or become an inaugural AiAdvocate in our policy leadership program!
Join the Knowledge = Empowerment Program
A virtual, patient-led classroom approach designed to help patients understand legislative issues affecting treatment access and connect them with opportunities to advocate for change.
#WTHellth?!
Share your frustrations with the healthcare system using #WTHellth. Prefer privacy? Submit a written rant anonymously through AiArthritis’ RANT! program, selecting the #WTHellth category.
